Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (GB:0Y6X)
LSE:0Y6X
Medtronic (0Y6X) Share Price & Analysis
3 Followers
0Y6X Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$67.74 - $88.93
Previous Close$81.19
Volume1.98K
Average Volume (3M)5.32K
Market Cap
$107.94B
Enterprise Value$125.00B
Total Cash (Recent Filing)$8.32B
Total Debt (Recent Filing)$25.18B
Price to Earnings (P/E)25.8
Beta0.75
Next Earnings
May 23, 2024EPS Estimate
$1.45Next Dividend Ex-DateN/A
Dividend Yield3.4%
Share Statistics
EPS (TTM)3.15
Shares Outstanding1,327,822,539
10 Day Avg. Volume24,014
30 Day Avg. Volume5,324
Standard Deviation0.06
R-Squared0.29
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-34.90
Price to Sales (P/S)17.31
Price to Cash Flow (P/CF)10.80
P/FCF Ratio11.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.87
Enterprise Value/Gross Profit6.10
Enterprise Value/Ebitda24.77
Forecast
1Y Price Target
$93.87Price Target Upside18.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Medtronic News
Bulls Say, Bears Say
Bulls Say
Clinical Trial ResultsThe first-in-human data for the Affera Sphere-360 PFA catheter in paroxysmal AFib are encouraging, showing high freedom from atrial arrhythmias, which could signal strong potential for its clinical adoption.
Financial PerformanceMDT's recent financial results beat expectations with notable organic sales growth, and the raised guidance reflects management's confidence in the company's ongoing strong performance.
Regulatory ApprovalFDA approval of MDT's next generation TAVR device, Evolut FX Plus, positions the company for increased competitiveness in the market with improved features for patient care.
Bears Say
Financial HealthForeign exchange and inflation pressures are recognized as challenges to margin expansion, despite positive growth indicators.
Market CompetitionMedtronic's US cryo business saw a decline due to competition from Boston Scientific's PolarX cryo device.
Product StrategyMedtronic's decision to exit ventilator products contrasts with their previous intention to spin the entire Patient Monitoring & Respiratory Interventions business.
---
0Y6X FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest share price was $67.74 and its highest was $88.93 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is May 23, 2024 which is in 23 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Feb 20, 2024. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of $1.262 by $0.038.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic does not currently pay dividends.
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.45.
How many shares outstanding does Medtronic have?
Medtronic has 1,327,822,500 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.3 in its last earnings report, beating expectations of $1.262. Following the earnings report the stock price went up 0.374%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 775M.
---
Medtronic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$93.87 (18.11% Upside)
$93.87 (18.11% Upside)
Blogger Sentiment
Bullish
GB:0Y6X Sentiment 92%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.40%
12-Months-Change
Fundamentals
Return on Equity
8.14%
Trailing 12-Months
Asset Growth
-3.50%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
0Y6X Company Deck
---
0Y6X Earnings Call
Q3 2024
0:00 / 0:00
---
0Y6X Net sales Breakdown
37.06% Cardiovascular
28.69% Neuroscience
27.01% Medical Surgical
7.24% Diabetes
---
0Y6X Stock 12 Months Forecast
Average Price Target
$93.87
▲(18.11% Upside)
Technical Analysis
Best Analysts Covering 0Y6X
1 Year
1 Year Success Rate
19/22 ratings generated profit
1 Year Average Return
+14.79%
reiterated a buy rating 5 months ago
Copying Kristen Stewart's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +14.79% per trade.
---